Joanne Quan
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joanne Quan
The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $3,246,216 for Joanne Quan in fiscal 2025, including a base salary of $520,000. Disclosed compensation is on record for 4 fiscal years. Joanne Quan has spoken on 4 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on May 6, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Mirum Pharmaceuticals, Inc. (MIRM)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Mirum Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | $520,000 | $3,246,216 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | $479,167 | $3,589,334 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | — | — |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | — | — |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.